Erik van den Berg: CEO of Memo Therapeutics episode artwork

EPISODE · Oct 27, 2025 · 30 MIN

Erik van den Berg: CEO of Memo Therapeutics

from BioBoss · host Erik van den Berg

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

NOW PLAYING

Erik van den Berg: CEO of Memo Therapeutics

0:00 30:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 30 minutes long.

When was this BioBoss episode published?

This episode was published on October 27, 2025.

What is this episode about?

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this BioBoss episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!